Kaye Spratt
About Kaye Spratt
Kaye Spratt serves as the Senior Vice President of Regulatory at Bridgebio and Abeona Therapeutics Inc., bringing extensive experience in regulatory affairs and microbiology. She has held significant roles in the biotechnology sector since the late 1990s, contributing to various organizations in California and New York.
Work at Abeona Therapeutics
Kaye Spratt has held multiple roles at Abeona Therapeutics Inc., serving as Vice President of Regulatory and Quality since 2015 and advancing to Senior Vice President, Regulatory in 2018. In her current role, she oversees regulatory strategies and ensures compliance with industry standards. Her experience in regulatory affairs contributes to the company's mission of developing innovative gene and cell therapies. Spratt's leadership in regulatory processes supports the advancement of Abeona's product pipeline.
Current Position at Bridgebio
Since 2019, Kaye Spratt has served as Senior Vice President at Bridgebio in Palo Alto, California. In this position, she is responsible for leading regulatory initiatives and strategies that align with the company's goals in developing therapies for genetic diseases. Her extensive background in regulatory affairs enhances Bridgebio's capabilities in navigating complex regulatory environments.
Previous Experience at Sangamo Therapeutics
Kaye Spratt worked at Sangamo Therapeutics for 17 years, from 1998 to 2015. During her tenure, she held the position of Director, where she was involved in preclinical and assay development. Her long-standing role at Sangamo provided her with significant experience in the biotechnology sector, particularly in regulatory and quality assurance processes.
Education and Expertise
Kaye Spratt studied Microbiology at Meharry Medical College from 1974 to 1979. Her educational background laid the foundation for her career in the biotechnology and pharmaceutical industries. Spratt's expertise encompasses regulatory affairs, quality assurance, and preclinical development, making her a valuable asset in her current and previous roles.